Filing metadata

Accession number
0001209191-23-022464
Form type
Form 3
Filer
Inozyme Pharma, Inc.
CIK
CIK 1693011
Filed
Apr 04, 2023
Reporting period
Apr 03, 2023
Description
Initial ownership

Explore SEC Filings Hub